MUMBAI, India, March 28 -- Intellectual Property India has published a patent application (202517021436 A) filed by Takeda Vaccines Inc., Cambridge, U.S.A., on March 10, for 'anti denv3 antibodies.'
Inventor(s) include Dominguez David; Watkins Heather; and Tsuji Isamu.
The application for the patent was published on March 28, under issue no. 13/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to anti dengue virus serotype 3 (DENV3) antibodies and antigen binding fragments thereof. Further nucleic acids encoding them and host cells comprising them are provided. In addition the use of the antibodies in the prevention or treatment of dengue disease is provided. Also diagnostic metho...